Earnings Release • May 12, 2022
Earnings Release
Open in ViewerOpens in native device viewer
PRESS RELEASE Milan, May 12, 2022
STRONG ORGANIC GROWTH IN CONSOLIDATED REVENUES AND IN ALL OPERATING INDICATORS COMPARED TO BOTH 1Q 2021 AND 4Q 2021
The Board of Directors of SAES Getters S.p.A., gathered today in Milan, approved the consolidated results of the first quarter of 2022 (January 1 - March 31).
"We are extremely satisfied with the results of SAES in the first quarter of 2022. All sectors recorded a strong growth, also thanks to the excellent trend of the euro-dollar exchange rate - Eng. Massimo della Porta, President of SAES Getters S.p.A. said - We expect the current situation of the Group to continue in the coming months, also thanks to the minimal operating impact of the difficult international geopolitical situation on SAES".
In the first quarter of 2022 the SAES® Group achieved consolidated net revenues equal to €59.2 million, compared to €41 million in the corresponding quarter of 2021. Excluding the exchange rate effect, positive and equal to +6.7% and the effect of the change in the scope of consolidation due to the acquisition of Strumenti Scientifici Cinel S.r.l. in July 2021 (+3.8%), the organic growth was equal to +33.7%. However, the comparison is not significant due to the still penalizing effect of the pandemic in the first months of 2021, mainly in the medical Nitinol business, penalized by the postponement of elective therapies.
All the Divisions recorded an organic growth, in particular the Medical Nitinol Division (+42.3%, equal to €7.6 million), favored by the post-Covid recovery and the related restocking actions. Also the High Vacuum Division recorded a strong organic growth (+63.7%, equal to €2 million), thanks to higher sales of vacuum pumps in all segments (particle accelerators, research institutes and industry), to which were added the revenues for the supply of vacuum systems to the RFX Consortium of Padua, active in experimental nuclear
| SAES Group – Press Release | ||||||
|---|---|---|---|---|---|---|
| fusion. Finally, please note the strong increase in the Packaging Division (+114.1%, equal to €1.9 million), that consolidated the signs of growth already observed at the end of 2021, due both to the expansion of the |
||||||
| customer portfolio and to the higher penetration of SAES products that represent an alternative to the use | ||||||
| of some plastic raw materials for which there is currently a market shortage. | ||||||
| Thousands of euro (except %) | ||||||
| Total | Organic | Exchange rate | Perimeter | |||
| Business | 1Q 2022 | 1Q 2021 | difference | change | effect | variation (%) |
| (%) | (%) | (%) | ||||
| 4.6% | 0.3% | 4.3% | 0.0% | |||
| Getters & Dispensers | 11,738 | 11,217 | ||||
| Sintered Materials | 2,560 | 1,900 | 34.7% | 25.4% | 9.3% | 0.0% |
| SMA Materials | 3,441 | 2,846 | 20.9% | 17.9% | 3.0% | 0.0% |
| SAES Industrial | 17,739 | 15,963 | 11.1% | 6.5% | 4.6% | 0.0% |
| High Vacuum Solutions | 6,887 | 3,182 | 116.4% | 63.7% | 4.0% | 48.7% |
| SAES High Vacuum | 6,887 | 3,182 | 116.4% | 63.7% | 4.0% | 48.7% |
| Medical Nitinol | 27,469 | 17,985 | 52.7% | 42.3% | 10.4% | 0.0% |
| SAES Medical Nitinol | 27,469 | 17,985 | 52.7% | 42.3% | 10.4% | 0.0% |
| Chemicals | 3,423 | 2,209 | 55.0% | 55.0% | 0.0% | 0.0% |
| SAES Chemicals | 3,423 | 2,209 | 55.0% | 55.0% | 0.0% | 0.0% |
| Packaging Solutions SAES Packaging |
3,638 3,638 |
1,699 1,699 |
114.1% 114.1% |
114.1% 114.1% |
0.0% 0.0% |
0.0% 0.0% |
Also in this case, the increase was concentrated in the Medical Nitinol Division (+12.4%, equal to €3 million, attributable both to the continuous growth of the final market and to the need to recover surgeries deferred during the Covid period as well as to the consequent restocking actions), in the Packaging Division (+90.6%, or €1.7 million, thanks to the consolidation of the success of the barrier technology offered by SAES in the market) and in the Industrial Division (+10.3%, or €1.6 million; a growth mainly concentrated in the SMA Materials business and distributed in all reference markets, namely luxury, automotive, consumer electronics and medical drug dispensing).
Finally, please note the organic breakeven of the High Vacuum Division and the organic decrease of the Chemicals Division attributable to the physiological slowdown that occurs every year in the first quarter compared to the fourth quarter of the previous year (-21.8%, equal to €1 million).
| Total | Organic | Exchange rate | |||
|---|---|---|---|---|---|
| Business | 1Q 2022 | 4Q 2021 | difference | change | effect |
| (%) | (%) | (%) | |||
| Getters & Dispensers | 11,738 | 11,124 | 5.5% | 4.3% | 1.2% |
| Sintered Materials | 2,560 | 2,323 | 10.2% | 8.1% | 2.1% |
| SMA Materials | 3,441 | 2,447 | 40.6% | 39.6% | 1.0% |
| SAES Industrial | 17,739 | 15,894 | 11.6% | 10.3% | 1.3% |
| High Vacuum Solutions | 6,887 | 6,901 | -0.2% | -0.9% | 0.7% |
| SAES High Vacuum | 6,887 | 6,901 | -0.2% | -0.9% | 0.7% |
| Medical Nitinol | 27,469 | 23,978 | 14.6% | 12.4% | 2.2% |
| SAES Medical Nitinol | 27,469 | 23,978 | 14.6% | 12.4% | 2.2% |
| Chemicals | 3,423 | 4,376 | -21.8% | -21.8% | 0.0% |
| SAES Chemicals | 3,423 | 4,376 | -21.8% | -21.8% | 0.0% |
| Packaging Solutions | 3,638 | 1,909 | 90.6% | 90.6% | 0.0% |
| SAES Packaging | 3,638 | 1,909 | 90.6% | 90.6% | 0.0% |
| Total Net Sales | 59,156 | 53,058 | 11.5% | 10.0% | 1.5% |
Thousands of euro (except %)
Including also the share of the revenues of the joint ventures1 , total revenues of the Group were equal to €60.3 million, compared to €43.6 million in the first quarter of 2021. The increase, equal to 38.2%, was exclusively due to the increase in consolidated net revenues (+44.1%), while the revenues of the joint venture Actuator Solutions GmbH were down (in the automotive sector sales were penalized by uncertainties on the supply chain and by the shortage of semiconductors; in the engineering and development sector there were lower sales of devices for Covid-19 rapid diagnostic tests), as well as those of the joint venture SAES RIAL Vacuum S.r.l. (sales were down following the conclusion of a particle accelerator project from which the company had benefited in the previous year). 1Q 2022 1Q 2021 Difference Consolidated sales 59,156 41,038 18,118 Total revenues of the Group 60,316 43,644 16,672
| Thousands of euro | |||
|---|---|---|---|
| 50% sales of the joint venture Actuator Solutions GmbH | 734 | 2,163 | (1,429) |
| 49% sales of the joint venture SAES RIAL Vacuum S.r.l. | 497 | 626 | (129) |
| 46.84% sales of the joint venture Flexterra | 0 0 |
0 | |
| Intercompany eliminations | (56) | (267) | 211 |
| Other adjustments | (15) | 84 | (99) |
Consolidated gross profit2 was equal to €26 million in the first quarter of 2022, strongly increased (+63.6%) compared to €15.9 million in the corresponding period of 2021, despite the penalizing effect of the energy expenses in the Italian manufacturing plants. All the Divisions recorded a growth, with the increase being mainly driven by higher revenues and their subsequent economies of scale, particularly in the Medical Nitinol Division and in the High Vacuum Division. Please note that the acquisition of Strumenti Scientifici Cinel S.r.l. contributed to the increase of gross profit for €0.5 million, while the exchange rate effect was positive and equal to €1.3 million.
Compared to fourth quarter of 2021, gross profit increased by +11.8% (from €23.3 million to €26 million), favored by the Industrial Division (mainly the SMA Materials business), as well as by the Medical Nitinol one.
Gross margin3 increased from 38.8% to 44%, in line with that of the last quarter of 2021 (43.9%). In the comparison between the first two quarters, also the gross margin, as well as the gross profit, increased in all the Divisions, particularly in the Medical Nitinol one, that has been progressively improving the production yield of the new tube department.
Consolidated operating income amounted to €10.3 million (17.3% of revenues) in the first quarter of 2022, showing an extraordinary growth compared to an operating income of €2.2 million (5.5% of revenues) in the first quarter of the previous year: the growth was the consequence of the better industrial performance of all the Divisions, despite the increase in operating expenses (especially personnel costs, related to the increase in the Group's workforce). Please note that the acquisition of Strumenti Scientifici Cinel S.r.l. contributed to the increase in the operating income for €0.3 million, while the exchange rate effect was positive and equal to €1 million.
Also compared to the fourth quarter of 20214 , both the operating income and the operating margin recorded a significant growth (+82.1% the increase in absolute terms, while the operating margin increased from 10.6% to 17.3%).
1 Actuator Solutions (50%), SAES RIAL Vacuum S.r.l. (49%) and Flexterra (46.84%).
2 Calculated as the difference between net sales and industrial costs directly and indirectly attributable to the products sold.
3 Calculated as the ratio between gross profit and consolidated revenues.
4 Please note that the operating income in the fourth quarter of 2021 was penalized by the write-down for impairment test in the packaging business (€1.5 million) and by the cancellation of an advance for a potential equity investment, which was then suspended, again in the packaging business (€1.1 million).
| SAES Group – Press Release | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thousands of euro | ||||||||||||||
| SAES Industrial | SAES High Vacuum | SAES Medical Nitinol | SAES Chemicals | SAES Packaging | Not Allocated | TOTAL | ||||||||
| 1Q 2022 | 1Q 2021 | 1Q 2022 | 1Q 2021 | 1Q 2022 | 1Q 2021 | 1Q 2022 | 1Q 2021 | 1Q 2022 | 1Q 2021 | 1Q 2022 | 1Q 2021 | 1Q 2022 | 1Q 2021 | |
| Total net sales Cost of sales |
17,739 (8,487) |
15,963 (7,640) |
6,887 (3,158) |
3,182 (1,619) |
27,469 (15,528) |
17,985 (12,238) |
3,423 (2,706) |
2,209 (1,759) |
3,638 (3,245) |
1,699 (1,591) |
0 0 |
0 (276) |
59,156 (33,124) |
41,038 (25,123) |
| Gross profit (loss) % on net sales |
9,252 52.2% |
8,323 52.1% |
3,729 54.1% |
1,563 49.1% |
11,941 43.5% |
5,747 32.0% |
717 20.9% |
450 20.4% |
393 10.8% |
108 6.4% |
0 n.a. |
(276) n.a. |
26,032 44.0% |
15,915 38.8% |
| Operating expenses and other income (expenses) Operating income (loss) |
(3,664) 5,588 |
(3,011) 5,312 |
(1,523) 2,206 |
(935) 628 |
(2,433) 9,508 |
(2,132) 3,615 |
(334) 383 |
(281) 169 |
(927) (534) |
(828) (720) |
(6,897) (6,897) |
(6,490) (6,766) |
(15,778) 10,254 |
(13,677) 2,238 |
| % on net sales | 31.5% | 33.3% | 32.0% | 19.7% | 34.6% | 20.1% | 11.2% | 7.7% | -14.7% | -42.4% | n.a. | n.a. | 17.3% | 5.5% |
| Thousands of euro | ||||||||||||||
| SAES Industrial | SAES High Vacuum | SAES Medical Nitinol | SAES Chemicals | SAES Packaging | Not Allocated | TOTAL | ||||||||
| 1Q 2022 | 4Q 2021 | 1Q 2022 | 4Q 2021 | 1Q 2022 | 4Q 2021 | 1Q 2022 | 4Q 2021 | 1Q 2022 | 4Q 2021 | 1Q 2022 | 4Q 2021 | 1Q 2022 | 4Q 2021 | |
| Total net sales | 17,739 | 15,894 | 6,887 | 6,901 | 27,469 | 23,978 | 3,423 | 4,376 | 3,638 | 1,909 | 0 | 0 | 59,156 | 53,058 |
| Cost of sales Gross profit (loss) |
9,252 | (8,487) (8,296) 7,598 |
(3,158) 3,729 |
(3,386) 3,515 |
(15,528) 11,941 |
(13,237) 10,741 |
(2,706) 717 |
(3,244) 1,132 |
(3,245) 393 |
(1,602) 307 |
0 0 |
(3) (3) |
(33,124) 26,032 |
(29,768) 23,290 |
| % on net sales Operating expenses and other income (expenses) |
52.2% (3,664) |
47.8% (3,141) |
54.1% (1,523) |
50.9% (1,676) |
43.5% (2,433) |
44.8% (2,203) |
20.9% (334) |
25.9% (373) |
10.8% (927) |
16.1% (3,614) |
n.a. (6,897) |
n.a. (6,652) |
44.0% (15,778) |
43.9% (17,659) |
| SAES Group – Press Release | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating expenses and other income (expenses) Operating income (loss) |
(3,664) 5,588 |
(3,011) 5,312 |
(1,523) 2,206 |
(935) 628 |
(2,433) 9,508 |
(2,132) 3,615 |
(334) 383 |
(281) 169 |
(927) (534) |
(828) (720) |
(6,897) (6,897) |
(6,490) (6,766) |
(15,778) 10,254 |
(13,677) 2,238 |
| % on net sales | 31.5% | 33.3% | 32.0% | 19.7% | 34.6% | 20.1% | 11.2% | 7.7% | -14.7% | -42.4% | n.a. | n.a. | 17.3% | 5.5% |
| Thousands of euro | SAES Industrial | SAES High Vacuum | SAES Medical Nitinol | SAES Chemicals | SAES Packaging | Not Allocated | TOTAL | |||||||
| Total net sales | 1Q 2022 17,739 |
4Q 2021 15,894 |
1Q 2022 6,887 |
4Q 2021 6,901 |
1Q 2022 27,469 |
4Q 2021 23,978 |
1Q 2022 3,423 |
4Q 2021 4,376 |
1Q 2022 3,638 |
4Q 2021 1,909 |
1Q 2022 0 |
4Q 2021 0 |
1Q 2022 59,156 |
4Q 2021 53,058 |
| Cost of sales | (8,487) (8,296) |
(3,158) | (3,386) | (15,528) | (13,237) | (2,706) | (3,244) | (3,245) | (1,602) | 0 | (3) | (33,124) | (29,768) | |
| Gross profit (loss) % on net sales |
9,252 52.2% |
7,598 47.8% |
3,729 54.1% |
3,515 50.9% |
11,941 43.5% |
10,741 44.8% |
717 20.9% |
1,132 25.9% |
393 10.8% |
307 16.1% |
0 n.a. |
(3) n.a. |
26,032 44.0% |
23,290 43.9% |
| Operating expenses and other income (expenses) | (3,664) | (3,141) | (1,523) | (1,676) | (2,433) | (2,203) | (334) | (373) | (927) | (3,614) | (6,897) | (6,652) | (15,778) | (17,659) |
| Operating income (loss) % on net sales |
5,588 31.5% |
4,457 28.0% |
2,206 32.0% |
1,839 26.6% |
9,508 34.6% |
8,538 35.6% |
383 11.2% |
759 17.3% |
(534) -14.7% |
(3,307) -173.2% |
(6,897) n.a. |
(6,655) n.a. |
10,254 17.3% |
5,631 10.6% |
| Consolidated EBITDA5 | was equal | to €13.7 million (23.1% of revenues), increased if compared to both the first | ||||||||||||
| quarter of 2021 (€5 million or 12.2% of revenues) and to the fourth quarter of 20216 | (€10.4 million or 19.6%) | |||||||||||||
| and reflected the operating income trend in all the Divisions. | ||||||||||||||
| Please note that, compared to the first quarter of 2021, the acquisition of Strumenti Scientifici Cinel S.r.l. | ||||||||||||||
| contributed to the increase in EBITDA for €0.3 million, while the exchange rate effect was positive and equal | ||||||||||||||
| to €1.1 million. | ||||||||||||||
| Thousands of euro | ||||||||||||||
| 1Q 2022 | 1Q 2021 | 4Q 2021 | ||||||||||||
| Operating income (loss) | 10,254 | 2,238 | 5,631 | |||||||||||
| Depreciation & amortization | (3,182) | (2,763) | (3,210) | |||||||||||
| Write-down of assets | (219) | (7) | (1,500) | |||||||||||
| Bad debt provision (Accrual)/Release | (28) | 1 | (54) |
| quarter of 2021 (€5 million or 12.2% of revenues) and to the fourth quarter of 20216 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Please note that, compared to the first quarter of 2021, the acquisition of Strumenti Scientifici Cinel S.r.l. contributed to the increase in EBITDA for €0.3 million, while the exchange rate effect was positive and equal |
|||||||||
| Thousands of euro | |||||||||
| Operating income (loss) | 1Q 2022 10,254 |
1Q 2021 | 2,238 | 4Q 2021 | 5,631 | ||||
| Depreciation & amortization | (3,182) | (2,763) | (3,210) | ||||||
| Write-down of assets | (219) | (7) | (1,500) | ||||||
| Bad debt provision (Accrual)/Release | EBITDA | (28) 13,683 |
1 5,007 |
(54) 10,395 |
Consolidated net income was equal to €1.9 million in the first quarter of 2022 (compared to €1.4 million in the corresponding quarter of 2021 and to €2.6 million in the fourth quarter of 2021) as it was heavily penalized by the negative performance of the securities portfolio (-€5.5 million) following the Ukraine-Russia crisis.
The consolidated net financial position was positive and equal to €71 million as at March 31, 2022 and compares with a positive net financial position equal to €74.8 million as at December 31, 2021. The decrease, despite a good result from operating activities (+€3.9 million) albeit penalized by the increase in the net working capital, was exclusively due to the decrease in the fair value of the securities in the portfolio following the Ukraine-Russia conflict (the performance of the securities was equal to -€5.5 million in the current quarter). Finally, please note a capex equal to -€2.4 million.
For further details, please refer to the following sections of this press release.
5 EBITDA is not deemed as an accounting measure under International Financial Reporting Standards (IFRSs); however, we believe that EBITDA is an important parameter for measuring the Group's performance and therefore it is presented as an alternative indicator. Since its calculation is not regulated by applicable accounting standards, the method applied by the Group may not be homogeneous with the ones adopted by other Groups. EBITDA is calculated as "Earnings before interests, taxes, depreciation and amortization".
6 Please note that the EBITDA in the fourth quarter of 2021 was penalized by the cancellation of the advance due to the not finalized potential acquisition in the packaging business (€1.1 million).
On January 24, 2022, the Italian Branch of Memry Corporation, based in Lainate, was established by notarial deed no. 996/671; this branch, together with the already operational German Branch, enables Memry Corporation's commercial expansion in the European market, also with scouting functions, with the aim of a larger penetration of the Group in the healthcare sector.
On January 31, 2022, the EUREKA! - Technology Transfer Fund ended its fundraising activities with a total fundraising of €62,675,500. On February 16, 2022, following the sixth and final Closing, the Parent Company obtained a reimbursement referring to both the costs and the investments of the fund, amounting to €5 thousand and SAES shareholding in the fund was diluted from 4.81% to 4.79%.
On March 7, 2022 SAES Getters S.p.A. made a payment of €49 thousand, including the share of the management fees and other costs, as well as the portion of an investment made by the fund in the company NOVAC S.r.l.7
On February 15, 2022, the Board of Directors of SAES Getters S.p.A. proposed the inclusion of the newly acquired Strumenti Scientifici Cinel S.r.l. in the scope of the national tax consolidation together with the other Group companies that are already part of it. The respective Boards of Directors approved this inclusion at the beginning of March. Therefore, Strumenti Scientifici Cinel S.r.l. is part of the national tax consolidation with retroactive effect starting from January 1, 2022.
On February 28, 2022, SAES RIAL Vacuum S.r.l. fully repaid the interest-bearing loan granted by the shareholder SAES Getters S.p.A. (principal amount equal to €49 thousand). On the same date, the joint venture also repaid the loan granted by the other shareholder, Rodofil S.r.l. (principal amount equal to €51 thousand).
On March 1, 2022, SAES Nitinol S.r.l. waived a further share of interest accrued on loans granted to the joint venture Actuator Solutions GmbH, amounting to €0.3 million8 . This waiver will have no effect on the consolidated financial statements, as the financial receivable related to the interest-bearing loan (both principal and interest amounts) had already been fully written down as at December 31, 2021, as it was deemed unlikely to be recovered.
Please note that the SAES Group decided to donate an amount of €100 thousand to support Ukraine. In particular, €70 thousand were given to a local volunteer network connected with the Ukrainian Embassy in Italy, and the remainder will be assigned to an Italian refugees' support organization.
Consolidated revenues of the SAES Industrial Division amounted to €17.7 million in the first quarter of 2022, up by 11.1% compared to €16 million in the corresponding quarter of 2021. The currency trend recorded a positive exchange rate effect equal to +4.6%, net of which revenues organically increased by 6.5%.
The organic increase was mainly concentrated in the SMA Materials business (+17.9%, equal to €0.5 million), mainly driven by the luxury sector and to a lesser extent by the consumer electronics and automotive sectors. A double-digit organic growth was also registered by the Sintered Materials business (+25.4%, equal to €0.5 million), thanks to an increase in demand in both the heat sink segment and in the electron emitter one.
7 NOVAC S.r.l. is an innovative start-up company operating in the field of electrical energy storage and release systems, through the development of a new type of supercapacitors, able to provide high power and very short charging times.
8 In addition to the interest share, equal to €0.5 million, that SAES Nitinol S.r.l. had already waived in June 2021.
| SAES Group – Press Release | |||||
|---|---|---|---|---|---|
| The Getters & Dispensers business was substantially stable: the increase in sales in the medical diagnostics and electronic devices markets was offset by a slight decrease in the other businesses. |
|||||
| The table below shows the revenues in the first quarter of 2022 related to the different business segments, with evidence of the exchange rate effect and of the organic change compared to the corresponding period of 2021. Thousands of euro (except %) |
|||||
| Total | Organic | Exchange rate | |||
| Business | 1Q 2022 | 1Q 2021 | difference (%) |
change (%) |
effect (%) |
| Getters & Dispensers | 11,738 | 11,217 | 4.6% | 0.3% | 4.3% |
| Sintered Materials SMA Materials |
2,560 3,441 |
1,900 2,846 |
34.7% 20.9% |
25.4% 17.9% |
9.3% 3.0% |
Gross profit of the Industrial Division was equal to €9.3 million in the first quarter of 2022, showing a double-digit increase (+11.2%) compared to €8.3 million in the corresponding period of 2021 thanks to higher sales, against a perfectly aligned gross margin (52.2% in the first quarter of 2022 compared to 52.1% in the corresponding period of 2021).
Operating income of the Industrial Division was equal to €5.6 million, up by 5.2% compared to €5.3 million in the first quarter of 2021 thanks to higher sales, although selling expenses increased in absolute terms but were essentially unchanged as a percentage of revenues. The operating margin decreased from 33.3% to 31.5%.
Consolidated revenues of the SAES High Vacuum Division were equal to €6.9 million in the first quarter of 2022, more than doubled compared to €3.2 million in the corresponding quarter of 2021. The currency trend recorded a positive exchange rate effect equal to +4%, while organic growth was equal to 63.7% (€2 million in absolute terms). Please note the change in the scope of consolidation following the acquisition of Strumenti Scientifici Cinel S.r.l. in July 2021 that led to a further increase in revenues of €1.5 million (+48.7%). Business 1Q 2022 1Q 2021 SAES High Vacuum 6,887 3,182 116.4% 63.7% 4.0% 48.7%
The excellent result was due to higher sales of NEG vacuum pumps in all segments (particle accelerators, research institutes and industry), to which were added the revenues for the supply of vacuum systems to the RFX Consortium in Padua, active in experimental nuclear fusion.
The table below shows the revenues in the first quarter of 2022, with evidence of the exchange rate effect, the change in the scope of consolidation and the organic change compared to the corresponding period of 2021.
| Total difference (%) |
Organic change (%) |
Exchange rate effect (%) |
Perimeter variation (%) |
|||
|---|---|---|---|---|---|---|
| High Vacuum Solutions | 6,887 | 3,182 | 116.4% | 63.7% | 4.0% | 48.7% |
Thousands of euro (except %)
Gross profit of the High Vacuum Division was equal to €3.7 million in the first quarter of 2022, more than doubled compared to €1.6 million in the first quarter of 2021, favored by higher sales, a different product mix and by the resulting economies of scale. Gross margin increased from 49.1% to 54.1%, despite the dilutive effect of the consolidation of Strumenti Scientifici Cinel S.r.l., that closed the first quarter of 2022 with a gross industrial margin slightly above 34%.
Operating income of the High Vacuum Division was equal to €2.2 million, more than tripled compared to €0.6 million in the first quarter of 2021, despite the slight increase in operating expenses, mainly attributable to the change in the scope of consolidation9 . The operating margin increased from 19.7% to 32%.
| compared to €0.6 million in the first quarter of 2021, despite the slight increase in operating | |||||
|---|---|---|---|---|---|
| expenses, mainly attributable to the change in the scope of consolidation9 increased from 19.7% to 32%. |
. The operating margin | ||||
| SAES Medical Nitinol Division | |||||
| Consolidated revenues of the SAES Medical Nitinol Division were equal to €27.5 million in the first quarter of 2022, up by 52.7% compared to €18 million in the corresponding period of 2021. The exchange rate effect was positive and equal to +10.4%, net of which the organic increase was equal to +42.3% (€7.6 million in absolute terms). |
|||||
| This increase was particularly significant, although it is necessary to consider that the first quarter of 2021 was still penalized by the pandemic and by the consequent postponement of elective surgeries. |
|||||
| The table below shows the revenues in the first quarter of 2022, with evidence of the exchange rate | |||||
| effect and of the organic change compared to the corresponding period of 2021. | |||||
| Thousands of euro (except %) Business |
1Q 2022 | 1Q 2021 | Total difference |
Organic change |
Exchange rate effect |
| Medical Nitinol | 27,469 | 17,985 | (%) 52.7% |
(%) 42.3% |
(%) 10.4% |
Gross profit of the Medical Nitinol Division was equal to €11.9 million in the first quarter of 2022, more than doubled when compared to €5.7 million in the corresponding period of 2021, while gross margin increased from 32% to 43.5%: the excellent performance of the Division was related both to the increase in revenues and to the progressive improvement in the production yield of the new tube department.
Operating income of the Medical Nitinol Division was equal to €9.5 million (34.6% of revenues), almost tripled compared to €3.6 million (20.1% of revenues) in the first quarter of 2021: the increase in gross profit reflected on the operating income, only partially mitigated by higher operating expenses (slight increase in personnel expenses in the G&A department and exchange rate effect).
Consolidated revenues of the SAES Chemicals Division were equal to €3.4 million in the first quarter of 2022, up by +55% compared to €2.2 million in the corresponding period of 2021. There was no exchange rate effect, being sales denominated exclusively in euro.
The very strong increase in sales of advanced materials for the consumer electronics segment was the result of the strong recovery in the final market's demand compared to the early months of 2021.
The table below shows the revenues in the first quarter of 2022, compared to the corresponding period of 2021.
9 Acquisition of Strumenti Scientifici Cinel S.r.l.
| Thousands of euro (except %) | |
|---|---|
| SAES Group – Press Release | ||||||
|---|---|---|---|---|---|---|
| Thousands of euro (except %) | ||||||
| Total | Organic | Exchange rate | ||||
| Business | 1Q 2022 | 1Q 2021 | difference (%) |
change (%) |
effect (%) |
|
| Chemicals | 3,423 | 2,209 | 55.0% | 55.0% | 0.0% | |
| SAES Chemicals | 3,423 | 2,209 | 55.0% | 55.0% | 0.0% | |
| Gross profit of the Chemicals Division was equal to €0.7 million in the first quarter of 2022, compared | ||||||
| to €0.4 million in the corresponding period of 2021, slightly up thanks to higher sales, with a gross margin aligned in the two quarters (from 20.4% to 20.9%). |
Operating income of the Chemicals Division was equal to €0.4 million (11.2% of revenues), compared to €0.2 million (7.7% of revenues) in the first quarter of 2021: the increase in operating income was in line with that of the gross profit and operating expenses were stable in absolute terms (€0.3 million in both periods).
Consolidated revenues of the SAES Packaging Division were equal to €3.6 million in the first quarter of 2022, more than doubled compared to €1.7 million in the first quarter of 2021. Sales were exclusively denominated in euro.
The excellent result was attributable to the strengthening of the growth already recorded at the end of 2021, following the strategic repositioning of SAES Coated Films S.p.A. from a coated films manufacturer into a packaging solution provider. In addition, please note that the market unavailability of some plastic raw materials favored a greater penetration of SAES products which are an alternative to them, generating an expansion of the traditional customer portfolio and allowing to introduce the innovative SAES barrier technology in the market with a greater contribution to sustainability. Business 1Q 2022 1Q 2021 SAES Packaging 3,638 1,699 114.1% 114.1% 0.0%
The table below shows the revenues in the first quarter of 2022 compared to the corresponding period in 2021.
| Total difference (%) |
Organic change (%) |
Exchange rate effect (%) |
|||
|---|---|---|---|---|---|
| Packaging Solutions | 3,638 | 1,699 | 114.1% | 114.1% | 0.0% |
Thousands of euro (except %)
Gross profit of the Packaging Division was equal to €0.4 million, more than tripled compared to €0.1 million in the first quarter of 2021, driven by increased revenues and by higher economies of scale (gross margin increased from 6.4% to 10.8%), despite the new lacquering line was not yet operating at full capacity.
The excellent industrial performance positively reflected at the operating level, with the operating loss decreasing from €-0.7 million in the first quarter of 2021 to €-0.5 million in the current period.
These include costs relating to basic research projects, aimed at diversifying into innovative businesses, as well as corporate costs (expenses that cannot be directly attributed or reasonably allocated to any business segment but refer to the Group as a whole).
The unallocated cost of goods sold, nil in 2022, was equal to -€0.3 million in the previous year and mainly referred to costs related to a project for the renovation and modernization of some production departments at the Lainate site, completed at the end of 2021.
Total unallocated operating costs amounted to -€6.8 million in the first quarter of 2022, compared to -€6.4 million in the corresponding period of 2021. The increase was mainly concentrated in R&D expenses (especially higher personnel and consultancy costs as well as costs for materials, aimed at the development of innovative and sustainable projects).
Finally, please note, under the item "other net income (expenses)" in the first quarter of 2022 the cost, equal to €70 thousand, for the donation to a local Ukrainian network connected with the Embassy in Italy.
Consolidated operating expenses were equal to €15.7 million (26.5% of revenues) in the first quarter of 2022, compared to €13.6 million (33.2% of revenues) in the corresponding period of the previous year. Net of the exchange rate effect (+€0.3 million), the increase in the first quarter of 2022 (equal to approximately €1.8 million) was concentrated in the selling expenses (higher personnel costs both for the increase in the workforce and for the change in the scope of consolidation related to the acquisition of Strumenti Scientifici Cinel S.r.l., as well as a slight increase in transport costs on sales) and in G&A expenses (also in this case, increase in the cost of personnel and expenses related to the aforementioned change in the scope of consolidation). R&D expenses slightly increased in absolute terms (personnel costs and consultancy costs, also related to the establishment of the new Design House department within the Parent Company, focused on the development of highly innovative and sustainable products and processes), but decreased as a percentage of revenues (from 6.9% to 5.4%).
***
The net balance of other net income (expenses) was substantially nil (negative for -€91 thousand) in the first quarter of 2022, compared to a still immaterial negative figure equal to -€57 thousand in the corresponding quarter of 2021. Please note that the amount recorded in the current quarter included the cost, equal to €70 thousand, for the donation to a local Ukrainian network connected with the Embassy in Italy.
The sum of the exchange rate differences recorded a slightly negative balance equal to -€152 thousand in the first quarter of 2022, compared with a negative figure of-€ 73 thousand in the corresponding quarter of the previous year (both mainly attributable to losses deriving from the fair value valuation of forward contracts entered to hedge dollar-based commercial transactions expected in the remainder of both years).
The net balance of financial income and expenses was negative and equal to -€5.8 million, almost entirely attributable to the decrease in the fair value of the securities portfolio following the crisis between Ukraine and Russia. Interest on both short-term and long-term loans amounted to -€0.1 million, showing a marked decrease compared to -€0.3 million in the first quarter of 2021, thanks to the early repayment by the Parent Company of almost all outstanding loans at the end of December 2021. In the first quarter of 2021 financial income and expenses were positive for +€0.3 million (mainly, net income on securities equal to +0.8 million, as well as the aforementioned interest equal to -€0.3 million).
The result deriving from the valuation with the equity method of the joint ventures was positive and equal to +€3 thousand in the first quarter of 2022, compared to a positive value of +€2 thousand as at March 31, 2021: in both years the result was fully attributable to the joint venture SAES RIAL Vacuum S.r.l.
Consolidated net income before taxes was positive and equal to +€4.3 million in the first quarter of 2022, almost doubled compared to +€2.5 million in the first quarter of 2021, despite the sharp reduction in the value of the securities portfolio due to conflict in Ukraine, thanks to the excellent performance of operating activities.
Income taxes amounted to €2.5 million in the first quarter of 2022, compared to €1.1 million in the first quarter of 2021, and mainly included the taxes of the US manufacturing companies. The increase in absolute terms was mainly attributable to the higher taxable income achieved by the latter, compared to the corresponding period of the previous year. 1Q 2022 1Q 2021 Net income (loss) per ordinary share 0.07861 0.03330 Net income (loss) per savings share 0.13855 0.13855
The Group's tax rate increased from 44.5% to 56.7%: the worsening was due to the fact that SAES Investments S.A. ended the quarter with a negative taxable income10, prudentially not valued as a deferred tax asset.
Consolidated net income was equal to +€1.9 million in the first quarter of 2022, increased when compared to +€1.4 million in the first quarter of the previous year.
In the first quarter of 2022 net income per ordinary share amounted to €0.07861 (compared to €0.03330 in the corresponding period of 2021) and net income per savings share amounted to €0.13855 (unchanged compared to the first quarter of 2021).
| Euro | |
|---|---|
Consolidated net financial position as at March 31, 2022 was positive and equal to €71 million compared to a positive consolidated net financial position equal to €74.8 million as at December 31, 2021. The first quarter ended with a positive operating management of +€3.9 million, although penalized by the increase in net working capital (-€8.8 million). The latter was mainly due to higher trade receivables (a consequence of the higher sales in the Medical Nitinol and Packaging Divisions in the first quarter of 2022, compared to the last months of 2021) and to the increase in inventory (mainly in the Chemicals Division, in anticipation of higher sales expected in the coming months).
Investment activities absorbed cash for -€8 million (negative performance of the securities portfolio for - €5.5 million due to the financial crisis related to the Ukraine-Russia conflict and capex equal to -€2.4 million; finally, please note the payment of -€44 thousand to the venture capital fund EUREKA!).
The financial management was negative and equal to -€0.3 million (mainly interest on bank loans and leasing contracts).
On the other hand, the exchange rate effect was positive and equal to +€0.7 million, mainly related to the effect of the revaluation of both the dollar and the renminbi on the cash in these currencies compared to December 31, 2021.
10 Loss caused by the negative performance of the securities portfolio held by the company, subsequent to the crisis between Ukraine and Russia.
| SAES Group – Press Release | |
|---|---|
| December 31, | |
| 2021 | |
| 9 | |
| 29,509 | |
| 29,518 | |
| 1 | |
| 94,655 9 |
|
| 0 | |
| 94,665 | |
| (63,935) | |
| (109) | |
| 0 | |
| (20) | |
| (2,409) | |
| (71,076) | (66,473) |
| 54,758 | 57,710 |
| 49 | |
| 1,595 | 1,424 |
| 70,555 | 71,887 |
| 72,150 | 73,360 |
| (52,182) | (52,199) |
| (3,712) | (4,070) |
| (55,894) | (56,269) |
| 16,256 | 17,091 |
| 71,014 | 74,801 |
| March 31, 2022 9 35,569 35,578 0 90,256 0 0 90,256 (68,577) (102) (109) (13) (2,275) 0 |
Starting from January 1, 2022, the Group is organized in the following technological competence areas (or "Divisions"):
Finally, please note that three main business lines have been identified within the SAES Industrial Division:
| The economic figures relating to 2021 have been reclassified according to the new operating structure, to allow a homogeneous comparison with 2022. |
SAES Group – Press Release | ||||||
|---|---|---|---|---|---|---|---|
| (Thousands of euro) | |||||||
| Business | 1Q 2021 | Reclass. | 1Q 2021 reclassified |
4Q 2021 | Reclass. | 4Q 2021 reclassified |
|
| Security & Defense | 4,290 | 0 | 4,290 | 4,121 | 0 | 4,121 | |
| Electronic Devices | 3,421 | 0 | 3,421 | 3,575 | 0 | 3,575 | |
| Healthcare Diagnostics | 1,219 | 0 | 1,219 | 1,461 | 0 | 1,461 | |
| Lamps | 829 | 0 | 829 | 678 | 0 | 678 | |
| Thermal Insulated Devices | 931 | 0 | 931 | 1,026 | 0 | 1,026 | |
| Organic Electronics | 0 | 527 | 527 | 0 | 263 | 263 | |
| Getters & Dispensers | 10,690 | 527 | 11,217 | 10,861 | 263 | 11,124 | |
| Sintered Materials | 1,900 | 0 | 1,900 | 2,323 | 0 | 2,323 | |
| SMA Materials | 2,846 | 0 | 2,846 | 2,447 | 0 | 2,447 | |
| SAES Industrial | 15,436 | 527 | 15,963 | 15,631 | 263 | 15,894 | |
| High Vacuum Solutions SAES High Vacuum |
3,182 3,182 |
0 0 |
3,182 3,182 |
6,901 6,901 |
0 0 |
6,901 6,901 |
|
| Medical Nitinol | 17,985 | 0 | 17,985 | 23,978 | 0 | 23,978 | |
| SAES Medical Nitinol | 17,985 | 0 | 17,985 | 23,978 | 0 | 23,978 | |
| Chemicals | 2,736 | (527) | 2,209 | 4,639 | (263) | 4,376 | |
| SAES Chemicals | 2,736 | (527) | 2,209 | 4,639 | (263) | 4,376 | |
| Packaging Solutions | 1,699 | 0 | 1,699 | 1,909 | 0 | 1,909 | |
| SAES Packaging | 1,699 | 0 | 1,699 | 1,909 | 0 | 1,909 | |
| Total Net Sales | 41,038 | 0 | 41,038 | 53,058 | 0 | 53,058 |
| Thousands of euro | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SAES Industrial | SAES High Vacuum | SAES Medical Nitinol | SAES Chemicals | SAES Packaging | Not Allocated | TOTAL | |||||||||||
| 10 2021 | Reclass. | 1O 2021 reclassified |
10 2021 | 1Q 2021 reclassified |
1O 2021 | 1O 2021 reclassified |
10 2021 | Reclass. | 10 2021 reclassified |
10 2021 | 1Q 2021 reclassified |
10 2021 | 10 2021 reclassified |
10 2021 Reclass. | 1Q 2021 reclassified |
||
| Total net sales | 15.436 | 527 | 15,963 | 3.182 | 3.182 | 17.985 | 17,985 | 2.736 | (527) | 2.209 | 1.699 | 1.699 | 41.038 | 41.038 | |||
| Cost of sales | 7.405 | (235) | (7,640) | (1,619) | (1.619) | (12.238) | (12.238) | (1,994) | 235 | (1,759) | (1.591) | (1.591) | (276) | (276) | (25, 123) | (25, 123) | |
| Gross profit (loss) | 8.031 | 292 | 8.323 | 1.563 | 1.563 | 5.747 | 5.747 | 742 | (292) | 450 | 108 | 108 | (276) | (276) | 15.915 | 15,915 | |
| % on net sales | 52.0% | 52.1% | 49.1% | 49.1% | 32.0% | 32.0% | 27.1% | 20.4% | 6.4% | 6.4% | n.a. | n.a. | 38.8% | 38.8% | |||
| Operating expenses and other income | (2.807) | (204) | (3,011) | (935) | (935) | (2, 132) | (2, 132) | (485) | 204 | (281) | (828) | (828) | (6.490) | (6.490) | (13,677) | (13, 677) | |
| Operating income (loss) | 5,224 | 5.312 | 628 | 628 | 3.615 | 3.615 | 257 | (88) | 169 | (720) | (720) | (6,766) | (6,766) | 2,238 | 2,238 | ||
| % on net sales | 33.8% | 33.3% | 19.7% | 19.7% | 20.1% | 20.1% | 9.4% | 7% | $-42.4%$ | $-42.4%$ | n.a. | n.a. | 5.5% | 5.5% |
Since the mandate of Deloitte & Touche S.p.A. for the legal audit of the accounts for the financial years 2013- 2021 expired after the approval of the Financial Statements as at December 31, 2021, on April 21, 2022 the Ordinary Shareholders' Meeting approved the reasoned proposal of the Board of Statutory Auditors regarding the assignment of the legal audit of the accounts for the financial years 2022-2030 to KPMG S.p.A.
On April 22, 2022, on the occasion of the Earth Day, the B!POD project (www.bipod.it) developed by the Design House of SAES was launched, aimed at using the Group's innovative technologies to improve food preservation and combat waste, while reducing CO2 emissions. In particular, the first device of B!POD, called DRO!D, was presented to the public: a system of recyclable plastic containers which allows to preserve different types of food five times more than usual through vacuum techniques. The device is characterized by highly innovative design and colors and by the use of entirely green plastics and materials.
Please note that the performance of the Group's securities portfolio was negative and equal to approximately -1.80% during the month of April 2022.
Following the completion of the due diligence, the Board of Directors of SAES Getters S.p.A. resolved to proceed with the acquisition of the entire share capital of SAES RIAL Vacuum S.r.l., of which SAES already holds 49%.
SAES RIAL Vacuum S.r.l., established at the end of 2015 and jointly controlled by SAES Getters S.p.A. (49%) and Rodofil S.r.l. (51%) is specialized in the design and manufacturing of vacuum chambers for accelerators, synchrotrons and industrial applications. The acquisition follows that of Strumenti Scientific Cinel S.r.l. (July 2021) and aims at strengthening the Group's competitive position in the high vacuum sector, through an expansion and integration of the offer, which is entirely Italian and at the forefront on a global scale.
The consideration for the acquisition will be equal to around €5.25 million and the closing is expected in the next few weeks, because of the technical time required to formalize the operation. A first tranche of the consideration, equal to €4,750 thousand, will be paid by SAES at the closing; the remaining part, equal to €500 thousand, will be withheld as a guarantee and paid in three successive annual installments of the same amount (each worth €166.7 thousand) starting from the thirty-sixth month following the signing of the deed of sale (March 2, 2022).
SAES RIAL Vacuum S.r.l., currently consolidated by using the equity method, recorded net revenues equal to €7 million and a net income equal to €0.4 million in 2021(net revenues equal to €5.6 million and a net income equal to €0.6 million in 2020). As at March 31, 2022, its shareholders' equity was equal to €2 million, while the net financial position was negative for €0.7 million.
Please note that the Group's direct exposure in Russia, Ukraine and Belarus is negligible. In 2021 the revenues, concentrated only in Russia, were immaterial. Also the forecasts for 2022, prepared before the crisis, confirm the irrelevance of these markets. Moreover, the Group has no suppliers from these countries and in any case it has decided to cautiously suspend any commercial activity towards Russia.
The unpredictable dynamics of the geopolitical, military and economic developments of the crisis, combined with the complex interdependencies among the world's economies and supply chains, do not allow us to provide firm estimates of the crisis' impact. The expected results of the operating activities are influenced by the evolution of the global macroeconomic context and the consequent repercussions on the cost of raw materials and energy.
***
Please note that these figures are taken from the Additional periodic financial information as at March 31, 2022, not subject to audit. This document will be available to the public both on the Company's website (www.saesgetters.com/investor-relations/financial-reports) and on the centralized storage system () within today.
The Officer responsible for the preparation of corporate financial reports of SAES Getters S.p.A. certifies that, in accordance with the second subsection of article 154-bis, part IV, title III, second paragraph, section V-bis, of Legislative Decree February 24, 1998, no. 58, the financial information included in the present document corresponds to book of account and book-keeping entries.
***
The Officer responsible for the preparation of corporate financial reports Giulio Canale
A pioneer in the development of getter technology, the SAES® Group is the world leader in a variety of scientific and industrial applications where stringent vacuum conditions are required. In 80 years of activity, the Group's getter solutions have been supporting technological innovation in the information display and lamp industries, in sophisticated high vacuum systems and in vacuum thermal insulation, in technologies spanning from large vacuum power tubes to miniaturized silicon-based microelectronic and micromechanical devices (MEMS).
Starting in 2004, by leveraging the core competencies in special metallurgy and in the materials science, the SAES Group has expanded its business into the advanced material markets, in particular the market of shape memory alloys, a family of materials characterized by super elasticity and by the property of assuming predefined forms when subjected to heat treatment. These special alloys, which
today are mainly applied in the biomedical sector, are also perfectly suited to the realization of actuator devices for the industrial sector (domotics, white goods industry, consumer electronics, healthcare, automotive and luxury sector).
More recently, SAES has expanded its business by developing a technological platform that integrates getter materials in a polymeric matrix. These products, initially developed for OLED displays, are currently used in new application sectors, among which optoelectronics, photonics and the mobile sector. Among the new applications, the advanced packaging is a significantly strategic one, in which SAES is offering a range of new products for the food sustainable packaging and aims to compete with recyclable and compostable solutions.
A total production capacity distributed in eleven facilities, a worldwide-based sale & service network and over 1,100 employees the Group is able to combine multi-cultural skills and experience and to be a truly global enterprise.
SAES Group is headquartered in the Milan area (Italy).
SAES Getters S.p.A. is listed on the Italian Stock Exchange Market, Euronext STAR segment, since 1986.
More information on the SAES Group is available in the website www.saesgetters.com.
Emanuela Foglia Investor Relations Manager Tel. +39 02 93178 273 E-mail: [email protected]
Corporate Media Relations Close to Media Tel. +39 02 70006237 Nicola Guglielmi E-mail: [email protected] Fiorella Poppi E-mail: [email protected]
| SAES Industrial Division | |||
|---|---|---|---|
| Getters & Dispensers | advanced photonics markets) | Traditional getters and dispensers, based on metal alloys, for several industrial applications (electronic vacuum devices for application in the security & defense sector, MEMS, X-ray tubes for diagnostic imaging systems, lighting and thermal insulation products, etc.), as well as dispensable getters based on functionalized polymers (OLED applications for the consumer electronics, optoelectronics and |
|
| Sintered Materials | solid-state components and lasers | Dispensable cathodes for electronic tubes and devices for thermal dissipation in | |
| SMA Materials | Shape memory alloys and super elastic materials and components for the industrial sector (domotics, white goods industry, consumer electronics, non-implantable medical business, automotive and luxury sector) |
||
| SAES High Vacuum Division | |||
| High Vacuum Solutions | research and in particle accelerators | Getter pumps for vacuum systems that find application in the industrial sector, in | |
| SAES Medical Nitinol Division | |||
| Medical Nitinol | Nitinol raw material and components for the biomedical sector | ||
| SAES Chemicals Division | |||
| Chemicals | Functional acoustic composites for consumer electronics applications and new functional materials being validated by prospects |
||
| SAES Packaging Division | |||
| Packaging Solutions | Lacquers and advanced plastic films for the sustainable packaging sector | ||
| Consolidated Net Sales by Geographic Location of Customer Thousands of euro |
|||
| Geographic Area | 1Q 2022 | 1Q 2021 | |
| Italy | 1,771 | 1,211 | |
| European Countries | 11,769 | 7,920 | |
| North America | 34,185 | 23,198 | |
| Japan | 1,857 | 1,936 |
| Medical Nitinol | Nitinol raw material and components for the biomedical sector | ||
|---|---|---|---|
| SAES Chemicals Division | |||
| Chemicals | Functional acoustic composites for consumer electronics applications and new functional materials being validated by prospects |
||
| SAES Packaging Division | |||
| Packaging Solutions | Lacquers and advanced plastic films for the sustainable packaging sector | ||
| Consolidated Net Sales by Geographic Location of Customer Thousands of euro |
|||
| Italy | 1,771 | 1,211 | |
| European Countries | 11,769 | 7,920 | |
| North America | 34,185 | 23,198 | |
| Japan | 1,857 | 1,936 | |
| South Korea | 687 | 501 | |
| China | 6,168 | 4,795 | |
| Rest of Asia | 1,390 | 1,064 | |
| Rest of the World | 1,329 | 413 | |
| Total Net Sales | 59,156 | 41,038 |
Thousands of euro
| 1Q 2022 | 1Q 2021 | |
|---|---|---|
| Total net sales | 59,156 | 41,038 |
| Cost of sales | (33,124) | (25,123) |
| Gross profit | 26,032 | 15,915 |
| R&D expenses | (3,193) | (2,828) |
| Selling expenses | (3,813) | (2,912) |
| G&A expenses | (8,653) | (7,881) |
| Write-down of trade receivables | (28) | 1 |
| Total operating expenses | (15,687) | (13,620) |
| Other income (expenses), net | (91) | (57) |
| Operating income (loss) | 10,254 | 2,238 |
| Interest and other financial income, net | (5,655) | 491 |
| Write-down of financial receivables and other financial assets | (130) | (168) |
| Income (loss) from equity method evalueted companies | 3 | 2 |
| Foreign exchange gains (losses), net | (152) | (73) |
| Income (loss) before taxes | 4,320 | 2,490 |
| Income taxes | (2,451) | (1,109) |
| Net income (loss) from continued operations | 1,869 | 1,381 |
| Income (loss) from discontinued operations | 0 | 0 |
| Net income (loss) before minority interest | 1,869 | 1,381 |
| Net income (loss) pertaining to minority interest | 0 | 0 |
| Net income (loss) pertaining to the Group | 1,869 | 1,381 |
Thousands of euro
| 1Q 2022 | 1Q 2021 | |
|---|---|---|
| Net income (loss) for the period from continued operations | 1,869 | 1,381 |
| Exchange differences on translation of foreign operations | 2,659 | 5,357 |
| Exchange differences on equity method evaluated companies | 0 | 0 |
| Total exchange differences | 2,659 | 5,357 |
| Total components that will be reclassified to the profit (loss) in the future | 2,659 | 5,357 |
| Other comprehensive income (loss), net of taxes | 2,659 | 5,357 |
| Total comprehensive income (loss), net of taxes | 4,528 | 6,738 |
| attributable to: | ||
| - Equity holders of the Parent Company | 4,528 | 6,738 |
| - Minority interests | 0 | 0 |
| SAES Group – Press Release | |||
|---|---|---|---|
| Consolidated Statement of Financial Position | |||
| Thousands of euro | |||
| March 31, | December 31, | ||
| 2022 | 2021 | ||
| Property, plant and equipment, net | 84,093 | 83,543 | |
| Intangible assets | 59,622 | 58,951 | |
| Right of use | 5,886 | 6,399 | |
| Securities | 70,555 | 71,887 | |
| Other non current assets | 15,340 | 14,840 | |
| Current assets | 206,868 | 195,252 | |
| Total Assets | 442,364 | 430,872 | |
| Shareholders' equity | 258,327 | 253,799 | |
| Minority interest in consolidated | 0 | 0 | |
| Total Shareholders' Equity | 258,327 | 253,799 | |
| Non current liabilities | 77,524 | 75,759 | |
| Current liabilities | 106,513 | 101,314 | |
| Total Liabilities and Shareholders' Equity | 442,364 | 430,872 | |
| Consolidated Cash Flows Statement | |||
| Thousands of euro | |||
| March 31, | December 31, | ||
|---|---|---|---|
| Property, plant and equipment, net | 2022 84,093 |
2021 83,543 |
|
| Intangible assets | 59,622 | 58,951 | |
| Right of use | 5,886 | 6,399 | |
| Securities | 70,555 | 71,887 | |
| Other non current assets | 15,340 | 14,840 | |
| Current assets | 206,868 | 195,252 | |
| Shareholders' equity | 258,327 | 253,799 | |
| Minority interest in consolidated | 0 | 0 | |
| Non current liabilities | 77,524 | 75,759 | |
| Current liabilities | 106,513 | 101,314 | |
| Total Liabilities and Shareholders' Equity | 442,364 | 430,872 | |
| Consolidated Cash Flows Statement | |||
| Thousands of euro | |||
| 1Q 2022 | 1Q 2021 | ||
| Net income (loss) from continued operations | 1,869 | 1,381 | |
| Current income taxes | 1,611 | 998 | |
| Change in deferred income taxes | 840 111 |
||
| Depreciation, amortization and write down of non current assets | 3,401 | 2,770 | |
| Net loss (gain) on disposal of fixed assets | 0 (1) |
||
| Interest and other financial (income) expenses, net | 5,928 | (325) | |
| Other non-monetary costs (revenues) | (211) | (828) | |
| 13,438 | 4,106 | ||
| Change in operating assets and liabilities | (8,847) | (5,458) | |
| Payments of termination indemnities and similar obligations | (71) (66) |
||
| Financial income received, net of payment of interests | (101) | (8) | |
| Taxes paid | (545) | (309) | |
| Net cash provided by (used by) operating activities | 3,874 | (1,735) | |
| Purchase of tangible and intangible assets, net of proceeds from sales | (2,431) | (3,095) | |
| Purchase of securities, net of disinvestments | (270) | 213 | |
| Income from securities, net of management fees | 474 626 |
||
| Purchase of other investments | (44) (26) |
||
| Cash flows provided by (used by) investing activities | (2,271) | (2,282) | |
| Proceeds from financial liabilities, net of repayments | 4,275 | 1,448 | |
| Financial receivables repaid (granted) from related parties | 49 0 |
||
| Financial receivables repaid (granted) from third parties | (148) | 0 | |
| Interests receipts on financial receivables from related parties | 1 1 |
||
| Dividends payment | 0 0 |
||
| Interests and other expenses paid on loans Repayment of financial liabilities for leased assets (interests included) |
(148) (649) |
(365) (627) |
|
| 0 | |||
| 457 | |||
| 1,404 | |||
| (2,156) | |||
| 30,700 | |||
| Cash and cash equivalents at the end of the period | 34,997 | 28,544 | |
| Other financial liabilities/assets Cash flows provided by (used by) financing activities Effect of exchange rate differences Increase (decrease) in cash and cash equivalents Cash and cash equivalents at the beginning of the period |
3,375 5,711 29,286 |
(5) 733 |
| SAES Group – Press Release | ||||||||
|---|---|---|---|---|---|---|---|---|
| *** | ||||||||
| Actuator Solutions - SAES Group interest (50%) | ||||||||
| Thousands of euro | March 31, | December 31, | ||||||
| Actuator Solutions GmbH | 2022 | 2021 | ||||||
| Statement of financial position | 50% | 50% | ||||||
| Non current assets | 2,568 | 2,654 | ||||||
| Current assets | 1,062 | 1,127 | ||||||
| Total Assets | 3,630 | 3,781 | ||||||
| Non current liabilities | 4,000 | 4,025 | ||||||
| Current liabilities | 1,748 | 1,878 | ||||||
| Total Liabilities | 5,748 | 5,903 | ||||||
| Capital Stock, Reserves and Retained Earnings | (2,122) | (2,711) | ||||||
| Net income (loss) for the period | 4 | 589 | ||||||
| Other comprehensive income (loss) for the period | 0 | 0 | ||||||
| Total Equity | (2,118) | (2,122) | ||||||
| Actuator Solutions GmbH | 1Q 2022 | 1Q 2021 | ||||||
| Statement of profit or loss | 50% | 50% | ||||||
| Total net sales | 734 | 2,163 | ||||||
| Cost of sales | (537) | (1,441) | ||||||
| Gross profit | 197 | 722 | ||||||
| Total operating expenses | (321) | (301) | ||||||
| Other income (expenses), net | 0 | 5 | ||||||
| Operating income (loss) Interests and other financial income, net |
(124) 126 |
426 (70) |
||||||
| Foreign exchange gains (losses), net | 1 | (5) | ||||||
| Income taxes | 1 | 0 | ||||||
| Net income (loss) | 4 | 351 | ||||||
| Exchange differences | 0 | 0 | ||||||
| Total comprehensive income (loss) for the period | 4 | 351 | ||||||
| SAES RIAL Vacuum S.r.l. - SAES Group interest (49%) | ||||||||
| Thousands of euro | ||||||||
| March 31, | December 31, | |||||||
| SAES RIAL Vacuum S.r.l. | 2022 | 2021 | ||||||
| Statement of financial position | 49% | 49% | ||||||
| Non current assets | 449 | 316 | ||||||
| Current assets | 1,651 | 1,693 | ||||||
| Total Assets | 2,100 | 2,009 | ||||||
| Non current liabilities | 232 | 178 | ||||||
| 896 | 862 | |||||||
| Current liabilities | ||||||||
| Total Liabilities | 1,128 | 1,040 | ||||||
| Capital Stock, Reserves and Retained Earnings | 969 759 |
| Other income (expenses), net | 0 | 5 |
|---|---|---|
| Interests and other financial income, net | 126 | (70) |
| Foreign exchange gains (losses), net | 1 | (5) |
| Income taxes | 1 | 0 |
| Exchange differences | 0 | 0 |
| SAES RIAL Vacuum S.r.l. - SAES Group interest (49%) Thousands of euro |
||
| SAES RIAL Vacuum S.r.l. | March 31, | December 31, |
| 2022 | 2021 | |
| Non current assets | 449 | 316 |
| Current assets | 1,651 | 1,693 |
| Total Assets | 2,100 | 2,009 |
| Non current liabilities | 232 | 178 |
| Current liabilities | 896 | 862 |
| Total Liabilities | 1,128 | 1,040 |
| Capital Stock, Reserves and Retained Earnings | 969 759 |
|
| 200 | ||
| Net income (loss) for the period | 3 | |
| Other comprehensive income (loss) for the period (*) | 0 10 |
|
| Total Equity | 972 | 969 |
| SAES Group – Press Release | ||
|---|---|---|
| SAES RIAL Vacuum S.r.l. | 1Q 2022 | 1Q 2021 |
| Statement of profit or loss | 49% | 49% |
| Total net sales | 497 | 626 |
| Cost of sales | (448) | (580) |
| Gross profit | 49 | 46 |
| Total operating expenses | (56) | (80) |
| Other income (expenses), net | 16 | 38 |
| Operating income (loss) | 9 | 4 |
| Interests and other financial income, net | (3) | (3) |
| Foreign exchange gains (losses), net | (3) | 1 |
| Income taxes | 0 | 0 |
| Net income (loss) | 3 | 2 |
| Actuarial gain (loss) on defined benefit plans, net of | 0 | 0 |
| Totale comprehensive income (loss) for the period | 3 | 2 |
| Flexterra - SAES Group interest (46.84%) | ||
| Thousands of euro | ||
| Flexterra | March 31, | December 31, |
| 2022 | 2021 | |
| Statement of financial position | 46.84% | 46.84% |
| Non current assets | 5,363 | 5,425 |
| Current assets | 585 | 808 |
| Total Assets | 5,948 | 6,233 |
| Non current liabilities | 0 | 7 |
| Cost of sales | (448) | (580) |
|---|---|---|
| Total operating expenses | (56) | (80) |
| Other income (expenses), net | 16 | 38 |
| Interests and other financial income, net | (3) | (3) |
| Foreign exchange gains (losses), net | (3) | 1 |
| Income taxes | 0 | 0 |
| Actuarial gain (loss) on defined benefit plans, net of | 0 | 0 |
| Flexterra - SAES Group interest (46.84%) | ||
| Thousands of euro | ||
| March 31, | December 31, | |
| Flexterra | 2022 | 2021 |
| Statement of financial position | 46.84% | 46.84% |
| Non current assets | 5,363 | 5,425 |
| Current assets | 585 | 808 |
| Total Assets | 5,948 | 6,233 |
| Non current liabilities | 0 | 7 |
| Current liabilities | 2,499 | 2,476 |
| Total Liabilities | 2,499 | 2,483 |
| Capital Stock, Reserves and Retained Earnings | 3,577 | 5,154 |
| Reserve for stock options plan | 173 | 173 |
| Net income (loss) for the period | (447) | (1,917) |
| Other comprehensive income (loss) for the period (*) | 146 | 340 |
| Total Equity | 3,449 | 3,750 |
| (*) Currency translation differences arising from the conversion in euro of the financial statements of Flexterra, Inc. | ||
| and of Flexterra Taiwan Co., Ltd. | ||
| Flexterra | 1Q 2022 | 1Q 2021 |
| Statement of profit or loss | 46.84% | 46.73% |
| Total net sales | 0 | 0 |
| Cost of sales | 0 | 0 |
| Gross profit | 0 | 0 |
| Total operating expenses | (324) | (479) |
| Other income (expenses), net | 0 | 2 |
| Operating income (loss) | (324) | (477) |
| Interests and other financial income, net | (43) | (26) |
| 0 | 7 | |||||
|---|---|---|---|---|---|---|
| 2,499 | 2,476 | |||||
| 3,577 | 5,154 | |||||
| 173 | 173 | |||||
| (447) | (1,917) | |||||
| (*) Currency translation differences arising from the conversion in euro of the financial statements of Flexterra, Inc. and of Flexterra Taiwan Co., Ltd. |
||||||
| 0 | 0 | |||||
| 0 | 0 | |||||
| 0 | 0 | |||||
| (324) | (479) | |||||
| 0 | 2 | |||||
| (324) | (477) | |||||
| (43) | (26) | |||||
| (84) | (30) | |||||
| 5 | ||||||
| 4 (447) |
(528) | |||||
| 146 | 260 | |||||
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.